Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency

Supportive Care in Cancer

Volumn 23, Issue 7, 2015, Pages 1843-1850

  Schloss, Janet M ^a   Colosimo, Maree ^a,b   Airey, Caroline ^c   Vitetta, Luis ^d,e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Hematology and Oncology Clinics of Australia   (Australia)

^c QUEENSLAND HEALTH   (Australia)

^d Institute of Medical Research   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; GRANISETRON; METOCLOPRAMIDE; ONDANSETRON; PEGFILGRASTIM; THYROXINE; ANTINEOPLASTIC AGENT;

ADULT; ARTHRALGIA; BREAST CANCER; CANCER PATIENT; CASE REPORT; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CYANOCOBALAMIN DEFICIENCY; DIARRHEA; DISEASE SEVERITY; DRUG ERUPTION; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; LATENT PERIOD; LETTER; MIDDLE AGED; MOTOR PERFORMANCE; MYALGIA; NAUSEA AND VOMITING; NEUROLOGIC EXAMINATION; NEUROLOGIST; OBESITY; OSTEOARTHRITIS; PAIN SEVERITY; PERIPHERAL NEUROPATHY; PHYSICAL CAPACITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEDENTARY LIFESTYLE; SURAL NERVE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WALKING DIFFICULTY; CHEMICALLY INDUCED; METABOLISM; NEOPLASMS; PATHOLOGY; VITAMIN B 12 DEFICIENCY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; NEOPLASMS; PERIPHERAL NERVOUS SYSTEM DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN B 12 DEFICIENCY;

EID: 84929955838     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2725-6     Document Type: Letter

References (12)

1. Ferrier J, Pereira V, Busserolles J, Authier N, Balayssac D (2013) Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 17(10):364
2. Cavaletti G, Nicolini G, Marmiroli P (2008) Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies. Front Biosci 13:3506–3524
3. Schloss J, Colosmio M, Airey C, Masci PP, Linnane AW, Vitetta L (2013) Nutraceuticals and Chemotherapy-induced Peripheral Neuropathy (CIPN): a systematic review. Clin Nutr 32(6):888–893
4. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence prevalence and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain 155(12):2461–2470
5. Armstrong T, Almadrones L, Gilbert MR (2005) Chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 32(2):305–311
6. Bhagra A, Rao RD (2007) Chemotherapy-induced neuropathy. Curr Oncol Rep 9(4):290–299
7. Vasquez S, Guidon M, McHugh E, Lennon O, Grogan L, Breathnach OS (2013) Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice. Ir J Med Sci 183(1):53–58
8. Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV (2013) Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 31(21):2699–2707
9. Vu T, Amin J, Ramos M, Flener V, Vanyo L, Tisman G (1993) New assay for the rapid determination of plasma holotranscobalamin II levels: preliminary evaluation in cancer patients. Am J Hematol 42(2):202–211
10. Hastings MM. Nerve Conduction Study Normal Values (2012):https://wiki.umms.med.umich.edu/display/NEURO/Nerve+Conduction+Study+Normal+Values]. Accessed Aug 2014
11. Baker H, Leevy CB, DeAngelis B, Frank O, Baker ER (1998) Cobalamin (vitamin B12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease. J Am Coll Nutr 17:235–238
12. Aaron S, Kumar S, Vijayan J, Jacob J, Alexander M, Gnanamuthu C (2005) Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurol India 53(1):55–58